Starling Oncology (STLN) Profit After Tax Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | 10.61% |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 52.79% |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | 20.66% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 11.68% |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 28.63% |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 15.98% |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 8.25% |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 53.25% |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 8.46% |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 16.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.64% |
| Mar 31, 2026 | 56.37% |
| Dec 31, 2025 | 35.62% |
| Sep 30, 2025 | -83.43% |
| Jun 30, 2025 | -46.11% |
| Mar 31, 2025 | -44.47% |
| Dec 31, 2024 | -9.08% |
| Sep 30, 2024 | -75.52% |
| Jun 30, 2024 | -89.73% |
| Mar 31, 2024 | -171.30% |
| Dec 31, 2023 | -16,637.01% |
| Sep 30, 2023 | -93.17% |
| Jun 30, 2023 | -86.17% |